Concomitant genetic alterations are associated with response to EGFR targeted therapy in patients with lung adenocarcinoma

BACKGROUND: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are considered to be more effective than chemotherapy in the treatment of EGFR-mutant advanced non-small cell lung cancer (NSCLC). However, in addition to EGFR-sensitive mutations, the genetic factors that affect the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Lung Cancer Res
Hlavní autoři: Chen, Hualin, Liu, Meilian, Dai, Zhiwei, Li, Shujun, Luo, Yiping, Wang, Yongcun, Su, Wenmei, Cai, Weijing, Yang, Donghong, Huang, Jian, Yang, Zhixiong
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481595/
https://ncbi.nlm.nih.gov/pubmed/32953500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-679
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky